This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fischer, S. M. Articles by Cameron, G. S. Search for Related Content PubMed PubMed Citation Articles by Fischer, S. M. Articles by Cameron, G. S.

Correlation of Phorbol Ester Promotion in the Resistant C57BL/6J Mouse with Sustained Hyperplasia but not Ornithine Decarboxylase or Protein Kinase C¹

University of Texas M. D. Anderson Cancer Center, Science Park-Research Division, Smithville, Texas 78957

The activation of protein kinase C, induction of ornithine decarboxylase (ODC), and hyperplasia have been suggested to be linked, sequential processes resulting from phorbol ester application to mouse skin. However, evidence is presented indicating that these events are not necessarily linked or dependent on one another and that significant differences exist in these responses between phorbol ester promotion sensitive (SSIN) and resistant (C57BL/6J) mice. The epidermis from SSIN mice treated with a single application of 12-O-tetradecanoylphorbol-13-acetate (TPA) displayed a large induction of ODC and a subsequent extensive hyperplasia. A second TPA treatment at 24 or 48 h after the first did not result in ODC induction (refractory state), and protein kinase C was shown to be down-regulated at these times. By 72 h, however, a responsive state had returned even through protein kinase C remained down-regulated.

The epidermis of C57BL/6J responds to a single application of TPA with a level of ODC induction similar to that of the SSIN mice. Protein kinase C was down-regulated by approximately 75% after 24 h and was virtually completely down-regulated at 48 and 72 h (95–97%). In contrast to the above findings for the sensitive mice, however, little, if any, hyperplasia was produced. In addition, while a second TPA treatment at 24 h did not result in ODC induction (refractory state), hyperplasia did occur within 24 to 48 h. When the second TPA application was given 48 h after the first, at a time when protein kinase C was down-regulated, an overinduction of ODC occurred, as well as subsequent hyperplasia. Furthermore, a significant number of papillomas resulted when these increased treatment frequencies, i.e., once a day or every other day, were used to promote dimethylbenz(a)anthracene-initiated C57BL/6J mice. It is concluded that, while hyperplasia remains an apparent requirement for tumor promotion, the ODC induction following an initial TPA treatment is insufficient for or not causally related to this hyperplasia. In addition, subsequent ODC induction, at least in the C57BL/6J mouse, is probably not mediated by protein kinase C.

¹ This work was supported by NIH Grants CA 42211 and 34443 (S. M. F.), and CA 46629 (A. P. B.), and American Cancer Society Grant SIG 14 (A. P. B.).

² To whom requests for reprints should be addressed.

Received 4/ 4/89. Revised 7/18/89. Accepted 8/29/89.

This article has been cited by other articles:

				M. Guo, P. A. Mathieu, B. Linebaugh, B. F. Sloane, and J. J. Reiners Jr. Phorbol Ester Activation of a Proteolytic Cascade Capable of Activating Latent Transforming Growth Factor-beta . A PROCESS INITIATED BY THE EXOCYTOSIS OF CATHEPSIN B J. Biol. Chem., April 19, 2002; 277(17): 14829 - 14837. [Abstract] [Full Text] [PDF]

				D. M. Owens and F. M. Watt Influence of {beta}1 Integrins on Epidermal Squamous Cell Carcinoma Formation in a Transgenic Mouse Model: {{alpha}}3{beta}1, but not {{alpha}}2{beta}1, Suppresses Malignant Conversion Cancer Res., July 1, 2001; 61(13): 5248 - 5254. [Abstract] [Full Text] [PDF]

				Y. Nakamura, K. Torikai, Y. Ohto, A. Murakami, T. Tanaka, and H. Ohigashi A simple phenolic antioxidant protocatechuic acid enhances tumor promotion and oxidative stress in female ICR mouse skin: dose- and timing-dependent enhancement and involvement of bioactivation by tyrosinase Carcinogenesis, October 1, 2000; 21(10): 1899 - 1907. [Abstract] [Full Text] [PDF]